Proactive research analyst John Savin speaks to Thomas Warner after releasing a new report on NanoViricides Inc (NYSE-A:NNVC), a development-stage company that is creating special-purpose nanomaterials for antiviral therapy. Savin gives an overview of what the company does, as well as its current operations and its financial situation. He highlights that NanoViricides is currently undertaking its first ever clinical trial, of an edible treatment for Covid-19 in India.
View source version on newsdirect.com: https://newsdirect.com/news/nanoviricides-testing-oral-gummy-and-syrup-covid-19-treatment-proactive-research-analyst-811701760
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Sahyadri Times journalist was involved in the writing and production of this article.